|
|
||||||||
-agonists
Department of Internal Medicine, University of Iowa College of Medicine, Iowa City, Iowa
Submitted 8 February 2006 ; accepted in final form 11 May 2006
The airway epithelium is an important barrier between the environment and subepithelial tissues. The epithelium is also divided into functionally restricted apical and basolateral domains, and this restriction is dependent on the elements of the barrier. The protease-activated receptor-2 (PAR2) receptor is expressed in airway epithelium, and its activation initiates multiple effects including enhanced airway inflammation and reactivity. We hypothesized that activation of PAR2 would interrupt E-cadherin adhesion and compromise the airway epithelial barrier. The PAR2-activating peptide (PAR2-AP, SLIGRL) caused an immediate
50% decrease in the transepithelial resistance of primary human airway epithelium that persisted for 610 min. The decrease in resistance was accompanied by an increase in mannitol flux across the epithelium and occurred in cystic fibrosis transmembrane conductance receptor (CFTR) epithelium pretreated with amiloride to block Na and Cl conductances, confirming that the decrease in resistance represented an increase in paracellular conductance. In parallel experiments, activation of PAR2 interrupted the adhesion of E-cadherin-expressing L cells and of primary airway epithelial cells to an immobilized E-cadherin extracellular domain, confirming the hypothesis that activation of PAR2 interrupts E-cadherin adhesion. Selective interruption of E-cadherin adhesion with antibody to E-cadherin decreased the transepithelial resistance of primary airway epithelium by >80%. Pretreatment of airway epithelium or the E-cadherin-expressing L cells with the long-acting
-agonist salmeterol prevented PAR2 activation from interrupting E-cadherin adhesion and compromising the airway epithelial barrier. Activation of PAR2 interrupts E-cadherin adhesion and compromises the airway epithelial barrier.
protease-activated receptor; histamine; barrier function
This article has been cited by other articles:
![]() |
M. C. Winter, S. S. Shasby, and D. M. Shasby PAR2 Interrupts E-Cadherin Adhesion and Decreases the Transepithelial Resistance of Epithelia by Phosphorylating Tyrosines 489 and 654 of Beta-Catenin Proceedings of the ATS, April 15, 2008; 5(3): 359 - 359. [Full Text] [PDF] |
||||
![]() |
M. C. Winter, S. Shasby, and D. M. Shasby Compromised E-cadherin adhesion and epithelial barrier function with activation of G protein-coupled receptors is rescued by Y-to-F mutations in {beta}-catenin Am J Physiol Lung Cell Mol Physiol, March 1, 2008; 294(3): L442 - L448. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Stevens Epithelium: sticking it out, together Am J Physiol Lung Cell Mol Physiol, March 1, 2008; 294(3): L440 - L441. [Full Text] [PDF] |
||||
![]() |
E. Ostrowska, E. Sokolova, and G. Reiser PAR-2 activation and LPS synergistically enhance inflammatory signaling in airway epithelial cells by raising PAR expression level and interleukin-8 release Am J Physiol Lung Cell Mol Physiol, November 1, 2007; 293(5): L1208 - L1218. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Shasby Cell-cell adhesion in lung endothelium Am J Physiol Lung Cell Mol Physiol, March 1, 2007; 292(3): L593 - L607. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |